Breast Cancer Treatment in Gurugram
Breast cancer is the most common cancer among Indian women, and also one of the most treatable when caught early. Dr. Sandeep Ramawat provides systemic treatment for all subtypes of breast cancer at the American Oncology Institute, Gurugram.
A subtype-driven treatment plan
Breast cancer is not a single disease. Hormone receptor status and HER2 status determine whether treatment is built around hormonal therapy, HER2-targeted therapy, chemotherapy, or a combination. Establishing the subtype from the biopsy is therefore the first step.
HER2-positive breast cancer
HER2-positive disease responds to anti-HER2 targeted therapy, which has transformed outcomes for this subtype. Dr. Ramawat has spoken on dual anti-HER2 therapy in locally advanced HER2-positive breast cancer at the 3rd Update in Oncology and Haematology, Lucknow.
Treatment before and after surgery
Systemic therapy may be given before surgery to shrink the tumour and make breast conservation possible, or after surgery to reduce the risk of recurrence. Which sequence suits a patient depends on the stage and subtype.
When to seek an opinion
A new breast lump, a change in breast or nipple shape, nipple discharge, or an abnormal mammogram should be evaluated promptly. Screening mammography is advised for women from the age of 40, and earlier where there is a strong family history.
Consulting for breast cancer in Gurugram
Dr. Sandeep Ramawat consults at the American Oncology Institute, Aarvy Healthcare Super Specialty Hospital, Sector 90, Gurugram. OPD hours are Monday to Saturday, 9:00 am - 6:00 pm. Please bring your biopsy report, imaging and any prior treatment records to the first visit.
Appointments: +91 95606 83949 · drsandeepramawat@gmail.com
Frequently asked questions
No. Many patients with hormone receptor positive, early-stage breast cancer are treated with hormonal therapy without chemotherapy. The decision is based on the subtype, stage, and in selected cases on genomic risk testing.
Early-stage breast cancer is curable in a large proportion of patients. Even in advanced disease, modern therapies can control the cancer for extended periods while maintaining quality of life.
Hair loss is associated with certain chemotherapy regimens, not with hormonal therapy or most targeted treatments. Whether it applies to a given patient depends on the exact drugs used, and it is discussed before treatment begins.
Speak to Dr. Ramawat
Consultations at the American Oncology Institute, Gurugram. Call directly or send your details on WhatsApp.